India Quarterly Results BSE NSE Announcements — May 15, 2026

To consider and approve the financial results for the period ended March 31, 2026

To consider and approve Audited Financial Results (Standalone and Consolidated) of the Company for the quarter and year ended March 31, 2026.

To consider and approve the financial results for the period ended March 31, 2026 and other business matters

To consider and approve the financial results for the period ended March 31, 2026 and other business matters

To consider and approve the financial results for the period and financial year ended March 31, 2026 and dividend for the financial year ended March 31, 2026

Pursuant to Regulation 29 and other applicable provisions of the SEBI (LODR) Regulations, we wish to inform the exchange that a meeting of the Board of Directors of the Company is scheduled to be held on Friday, 15th May 2026, inter alia, to consider and approve the Audited Financial Results (Standalone and Consolidated) of the Company, for the quarter and financial year ended 31st March, 2026.

To consider and approve the financial results for the period ended March 31, 2026, dividend and other business matters

To consider and approve the financial results for the period ended March 31, 2026

To consider and approve the financial results for the period ended March 31, 2026 and dividend

To consider and approve the financial results for the period ended March 31, 2026 and other business matters

To consider and approve the financial results for the period ended March 31, 2026 and other business matters.

To consider and approve the financial results for the quarter and financial year ended March 31, 2026.

To consider and approve the Audited Financial Results of the Company for the Quarter and Year ended on March 31, 2026 together with the Statement of Assets and Liabilities as on that date and Statement of Cash Flows for the Financial Year ended on March 31, 2026 and to take on record Auditor s report thereon.

To consider and approve the financial results for the period ended March 31, 2026, dividend and Fund Raising

Intimation of Board Meeting inter-alia, for:i. Consideration of Audited Financial Results (both Standalone and Consolidated) for the Fourth Quarter and Financial Year ended on 31st March, 2026;ii. Recommendation of Final Dividend, if any, on the Equity Shares of the Company for the Financial Year ended on 31st March, 2026;iii. Analysis/Deliberation regarding Buy back of shares, Issue of Bonus Shares and Splitting of Shares in light of evaluation of Consolidated Guidelines on general principles and mechanism for Capital Restructuring of CPSEs issued by Ministry of Finance, Department of Investment & Public Asset Management (DIPAM)

To consider and approve the Audited Financial Results (Standalone and Consolidated) for the Quarter and Year Ended March 31, 2026

Intimation of Meeting of Board of Directors of the Company pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

To consider and approve the financial results for the period ended March 31, 2026, dividend and other business matters

To consider and approve the financial results for the period ended March 31, 2026 and dividend

To consider and approve the financial results for the period ended March 31, 2026

To consider and approve the financial results for the period ended March 31, 2026 and other business matters

To consider and approve the financial results for the period ended March 31, 2026 and other business matters

To consider and approve the financial results for the period ended March 31, 2026 and other business matters

To consider and approve the financial results for the period ended March 31, 2026 and dividend

To consider and approve the financial results for the Quarter and Financial Year ended March 31, 2026 and other business matters

To consider and approve the financial results for the period ended March 31, 2026 and dividend

To consider and approve the financial results for the period ended March 31, 2026 and dividend

To consider and approve the financial results for the period ended March 31, 2026, dividend and other business matters

To consider and approve the financial results for the period ended March 31, 2026 and dividend

To consider and approve the financial results for the quarter and financial year ended March 31, 2026.

To consider and approve the financial results for the period ended March 31, 2026

To consider and approve the financial results for the period ended March 31, 2026, dividend, Fund Raising and other business matters

To consider and approve the financial results for the period ended March 31, 2026 and dividend

To consider and approve the financial results for the period ended March 31, 2026, dividend and other business matters

To consider and approve the financial results for the period ended March 31, 2026 and dividend

To consider and approve the financial results for the period ended March 31, 2026, Fund Raising and other business matters

To consider and approve the financial results for the period ended March 31, 2026 and other business matters

To consider and approve the financial results for the period ended March 31, 2026 and dividend

To consider and approve the financial results for the period ended March 31, 2026 and dividend

To consider and approve the financial results for the period ended March 31, 2026, dividend and Fund Raising

To consider and approve the Standalone and Consolidated Financial Results of the Company for the quarter and year ended March 31, 2026

To consider and approve the financial results for the period ended March 31, 2026 and dividend

To consider other business matters

To consider and approve the financial results for the period ended March 31, 2026, and other business matters

To consider and approve the audited standalone and consolidated financial results for the period ended March 31, 2026.

To consider and approve the financial results for the period ended March 31, 2026 and recommend the final dividend

To consider and approve the financial results for the period ended March 31, 2026

To consider and approve the financial results for the period ended March 31, 2026

To consider and approve the financial results for the period ended March 31, 2026

To consider and approve the financial results for the period ended March 31, 2026

To consider and approve the financial results for the fourth quarter and financial year ended on March 31, 2026 and recommendation of dividend, if any.

To consider and approve the financial results for the period ended March 31, 2026

To consider and approve the financial results for the period ended March 31, 2026 and other business matters

To consider and approve the financial results for the period ended March 31, 2026 and dividend

The meeting of the Board of Directors of the Company is scheduled on 15/05/2026, inter alia, to consider and approve the Audited Financial Results (Standalone & Consolidated) of the Company for the Fourth Quarter (Q4) and Financial Year ended 31 March 2026, and the recommendation of Final Dividend (if any).

To consider and approve the financial results for the period ended March 31, 2026, Fund Raising and other business matters

To consider and approve the financial results for the period ended March 31, 2026 and dividend

To consider and approve the financial results for the period ended March 31, 2026 and dividend

To consider the financial results for the quarter and year ended March 31, 2026, recommendation of final dividend, if any, for FY 2025-26, and perusal of KID (Fund Raising)

To consider and approve the audited financial results for the quarter / year ended March 31, 2026

To consider and approve the Financial Results (Standalone & Consolidated) for the quarter and financial year ended on March 31, 2026 and other business matters

To consider and approve the financial results for the period ended March 31, 2026 and other business matters

To consider and approve the financial results for the period ended March 31, 2026, dividend and other business matters

PODDARMENT : 15-May-2026 : The Company has informed the Exchange that a Board meeting to be held on May 14, 2026 has been re-scheduled. Further, the Company has informed the Exchange that the meeting of the Board of Directors of the Company will be held on May 15, 2026, To consider and approve the financial results for the period ended March 31, 2026 and dividend

POWERGRID : 15-May-2026 : The Company has informed the Exchange that a Board meeting to be held on May 16, 2026 has been re-scheduled. Further, the Company has informed the Exchange that the meeting of the Board of Directors of the Company will be held on May 15, 2026, To consider and approve the financial results for the period ended March 31, 2026 and dividend

To consider and approve the financial results for the period ended March 31, 2026

To consider and approve the audited financial results for the quarter and year ended March 31, 2026 and other business matters

RANE HOLDINGS LTD. has informed NSE that the meeting of the Board of Directors of the Company is scheduled on May 15, 2026, inter alia, to consider and approve the Audited Financial Results for the quarter and year ending March 31, 2026. Further, in accordance with Rane's Insider code, the 'Trading window' would remain closed for Promoters, Directors, other connected persons and designated employees of the company from March 31, 2026 to May 17, 2026 (both days inclusive) for the above purpose.

To consider and approve the financial results for the period ended March 31, 2026 and dividend

To consider and approve the financial results for the period ended March 31, 2026

To consider other business matters

Notice of Board Meeting to consider Audited Standalone and Consolidated Financial Results for the quarter and financial year ended March 31, 2026

To consider and approve the financial results for the quarter and year ended March 31, 2026

To consider and approve the financial results for the period ended March 31, 2026 and dividend

Solara Active Pharma Sciences Limited has informed the exchange that the meeting of the Board of Directors of the Company is scheduled to be held on May 15, 2026, inter alia, to consider and approve the audited standalone and consolidated financial results of the Company for the quarter and year ended on March 31, 2026

To consider and approve the financial results for the period ended March 31, 2026 and dividend

To consider and approve the financial results for the period ended March 31, 2026 and dividend

To consider and approve the financial results for the period ended March 31, 2026, dividend and other business matters

Supreme Holdings & Hospitality (India) Limited has informed the Exchange that the meeting of the Board of Directors of the Company is scheduled on May 15, 2026 ,inter alia, to consider and approve the Audited Standalone and Consolidated Financial Results of the Company for the Quarter and Financial Year ending on March 31, 2026, and to take on record the Reports of the Auditors thereon.

Board Meeting Intimation inter alia, to consider and approve: 1. Audited Standalone and Consolidated Financial Results for the fourth quarter and financial year ended on March 31, 2026; and 2. Recommend final dividend on equity shares, if any, for the financial year 2025-26

To consider and approve the financial results for the period ended March 31, 2026, dividend and other business matters

To consider and approve the financial results for the period ended March 31, 2026 and dividend

To consider and approve the financial results for the period ended March 31, 2026

To consider and approve the financial results for the period ended March 31, 2026 and dividend

Triveni Engineering & Industries Limited has informed the Exchange that the meeting of the Board of Directors of the Company scheduled to be held on May 15, 2026 To consider and approve the financial results for the period ended March 31, 2026 and dividend has been postponed

To consider and approve the audited standalone and consolidated financial results for the fourth quarter and financial year ending on March 31, 2026 and recommend the payment of final dividend, if any, for the Financial Year 2025-26.

To consider and approve the financial results for the period ended March 31, 2026 and dividend

To consider and approve the Audited Standalone and Consolidated Financial Results for the quarter and year ended March 31, 2026

To consider and approve the financial results for the period ended March 31, 2026 and dividend

To consider and approve the financial results for the period ended March 31, 2026, recommendation of dividend, if any and proposal for Buyback of fully paid Equity Shares of the Company.

To consider and approve the financial results for the period ended March 31, 2026

To consider and approve the audited financial results for the period ended March 31, 2026 and declaration of final dividend if any

To consider and approve the financial results for the period ended March 31, 2026